Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
  2. Clark, David J; Dhanasekaran, Saravana M; Petralia, Francesca; Pan, Jianbo; Song, Xiaoyu; Hu, Yingwei; da Veiga Leprevost, Felipe; Reva, Boris; Lih, Tung-Shing M; Chang, Hui-Yin; Ma, Weiping; Huang, Chen; Ricketts, Christopher J; Chen, Lijun; Krek, Azra; Li, Yize; Rykunov, Dmitry; Li, Qing Kay; Chen, Lin S; Ozbek, Umut; Vasaikar, Suhas; Wu, Yige; Yoo, Seungyeul; Chowdhury, Shrabanti; Wyczalkowski, Matthew A; Ji, Jiayi; Schnaubelt, Michael; Kong, Andy; Sethuraman, Sunantha; Avtonomov, Dmitry M; Ao, Minghui; Colaprico, Antonio; Cao, Song; Cho, Kyung-Cho; Kalayci, Selim; Ma, Shiyong; Liu, Wenke; Ruggles, Kelly; Calinawan, Anna; Gümüs, Zeynep H; Geizler, Daniel; Kawaler, Emily; Teo, Guo Ci; Wen, Bo; Zhang, Yuping; Keegan, Sarah; Li, Kai; Chen, Feng; Edwards, Nathan; Pierorazio, Phillip M; Chen, Xi Steven; Pavlovich, Christian P; Hakimi, A Ari; Brominski, Gabriel; Hsieh, James J; Antczak, Andrzej; Omelchenko, Tatiana; Lubinski, Jan; Wiznerowicz, Maciej; Linehan, W Marston; Kinsinger, Christopher R; Thiagarajan,Mathangi; Boja, Emily S; Mesri, Mehdi; Hiltke, Tara; Robles, Ana I; Rodriguez, Henry; Qian, Jiang; Fenyö, David; Zhang, Bing; Ding, Li; Schadt, Eric; Chinnaiyan, Arul M; Zhang, Zhen; Omenn, Gilbert S; Cieslik, Marcin; Chan, Daniel W; Nesvizhskii, Alexey I; Wang, Pei; Zhang, Hui
  3. Cell. 2019, Oct 31; 179(4): 964-983.e31.
  1. 2.   Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2 alpha induced gene expression
  2. Grkovic, T.; Whitson, E. L.; Rabe, D. C.; Gardella, R. S.; Bottaro, D. P.; Linehan, W. M.; McMahon, J. B.; Gustafson, K. R.; McKee, T. C.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Apr; 21(7): 2113-2115.
  1. 3.   RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene
  2. Brauweiler, A.; Lorick, K. L.; Lee, J. P.; Tsai, Y. C.; Chan, D.; Weissman, A. M.; Drabkin, H. A.; Gemmill, R. M.
  3. Oncogene. 2007, Apr; 26(16): 2263-2271.
  1. 4.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 5.   STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker
  2. Ivanova, A.; Liao, S. Y.; Lerman, M. I.; Ivanov, S.; Stanbridge, E. J.
  3. Journal of Medical Genetics. 2005, JUL; 42(7): 565-576.
  1. 6.   High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors
  2. Vocke, C. D.; Yang, Y. F.; Pavlovich, C. P.; Schmidt, L. S.; Nickerson, M. L.; Torres-Cabala, C. A.; Merino, M. J.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. Journal of the National Cancer Institute. 2005, JUN 15; 97(12): 931-935.
  1. 7.   Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L
  2. Lee, J. K.; Seki, N.; Sayers, T. J.; Subleski, J.; Gruys, E. M.; Murphy, W. J.; Wiltrout, R. H.
  3. Cellular Immunology. 2005, JUN; 235(2): 145-152.
  1. 8.   Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
  2. Brooks, A. D.; Sayers, T. J.
  3. Cancer Immunology Immunotherapy. 2005, MAY; 54(5): 499-505.
  1. 9.   Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome
  2. Pavlovich, C. P.; Grubb, R. L.; Hurley, K.; Glenn, G. M.; Toro, J.; Schmidt, L. S.; Torres-Cabala, C.; Merino, M. J.; Zbar, B.; Choyke, P.; Walther, M. M.; Linehan, W. M.
  3. Journal of Urology. 2005, MAY; 173(5): 1482-1486.
  1. 10.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
  1. 11.   Birt-Hogg-Dube syndrome, a genodermatosis that increases risk for renal carcinoma
  2. Schmidt, L. S.
  3. Current Molecular Medicine. 2004, DEC; 4(8): 877-885.
  1. 12.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 13.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 14.   Sensitivity of renal cell carcinoma to aminoflavone: Role of CYP1A1
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Hose, C.; Linehan, W. M.; Worrell, R.; Rubinstein, L.; Sausville, A.; Vistica, D. T.
  3. Journal of Urology. 2004 171(4): 1688-1697.
  1. 15.   A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
  2. Okimoto, K.; Sakurai, J.; Kobayashi, T.; Mitani, H.; Hirayama, Y.; Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.; Hino, O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(7): 2023-2027.
  1. 16.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 17.   Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
  2. Nickerson, M. L.; Warren, M. B.; Toro, J. R.; Matrosova, V.; Glenn, G.; Turner, M. L.; Duray, P.; Merino, M.; Choyke, P.; Pavlovich, C. P.; Sharma, N.; Walther, M.; Munroe, D.; Hill, R.; Maher, E.; Greenberg, C.; Lerman, M. I.; Linehan, W. M.; Zbar, B.; Schmidt, L. S.
  3. Cancer Cell. 2002 2(2): 157-164.
  1. 18.   Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
  2. Danilkovitch-Miagkova, A.; Zbar, B.
  3. Journal of Clinical Investigation. 2002 109(7): 863-867.
  1. 19.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 20.   Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
  2. Miller, M.; Ginalski, K.; Lesyng, B.; Nakaigawa, N.; Schmidt, L.; Zbar, B.
  3. Proteins-Structure Function and Genetics. 2001 44(1): 32-43.
  1. 21.   Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway
  2. Danilkovitch-Miagkova, A.; Miagkov, A.; Skeel, A.; Nakaigawa, N.; Zbar, B.; Leonard, E. J.
  3. Molecular and Cellular Biology. 2001 21(17): 5857-5868.
  1. 22.   A novel germ line juxtamembrane Met mutation in human gastric cancer
  2. Lee, J. H.; Han, S. U.; Cho, H.; Jennings, B.; Gerrard, B.; Dean, M.; Schmidt, L.; Zbar, B.; Vande Woude, G. F.
  3. Oncogene. 2000 19(43): 4947-4953.
  1. 23.   Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
  2. Nakaigawa, N.; Weirich, G.; Schmidt, L.; Zbar, B.
  3. Oncogene. 2000 19(26): 2996-3002.
  1. 24.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
  1. 25.   Selective toxicity of the tricyclic thiophene NSC652287 in renal carcinoma cell lines - Differential accumulation and metabolism
  2. Rivera, M. I.; Stinson, S. F.; Vistica, D. T.; Jorden, J. L.; Kenney, S.; Sausville, E. A.
  3. Biochemical Pharmacology. 1999 57(11): 1283-1295.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel